The published results show that a combination of AKT inhibitors improves the sensitivity of cancer cells to chemotherapy and radiotherapy 30, 31, suggesting that the PI3K/AKT signaling pathway is closely related to GC resistance to CDDP. The gene discussed is AKT1; the disease is cancer.